The shocking reality:
- Conventional cultures show only 9% striated myotubes (vs 61% needed for accurate modeling)
- Zero functional acetylcholine receptors in standard human muscle cultures
- 5-fold higher variability making drug effects nearly impossible to detect
Enter MyoScreen by CYTOO 🎯
Our micropatterning technology creates what others couldn’t:
📈 Game-changing performance:
- 11-fold increase in muscle cell fusion after just 24h
- First-ever spontaneous AChR clusters in human myotubes without neurons
- 55% hit confirmation rate in drug screening (vs industry standard <10%)
- Successfully predicted muscle toxicity of 6 statins matching clinical data
💊 Real impact: From 2,560 compounds screened, we identified 2 novel muscle regeneration candidates with:
- CYT3818: Active at 7.5 picomolar (1000x more potent than current treatments)
- CYT9733: 203% increase in muscle differentiation
The bottom line: MyoScreen transforms a 70% drug failure rate into predictive success, saving pharma companies millions while accelerating treatments for muscle wasting affecting 50M+ patients worldwide.
